港股異動 | 移卡(9923.HK)漲2% 獲納入港股通股票名單 今日生效
格隆匯9月7日丨移卡(6078.HK)現報55港元,漲2%,暫成交1600萬港元,最新總市值234億港元。該股於今年6月1日在港交所上市,自7月以來持續大漲,並於8月11日盤中高見80港元創上市新高,現較發行價16.64港元已累漲超2.3倍。深交所上週五(4日)宣佈,移卡獲納入深港通下的港股通股票名單,自9月7日(即今日)起生效。此外據悉,公司曾發佈中期業績稱,報告期內公司總體業績與2019年同期相比錄得顯著增長,期內總收入10.77億元(人民幣,下同),同比增長5.1%;淨利潤2.23億元,基本每股盈利1.07元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.